| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Crispr Therapeutics AG (CRSP) has 7 insiders with recent SEC Form 4 filings, including 0 buys and 24 sells. CRSP is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 255.5K | $13.89M | - | |
| Dir | 22.0K | $1.20M | - | |
| CFO | 19.5K | $1.06M | - | |
| Other | 19.4K | $1.05M | -3,786 | |
| Other | 17.0K | $924.1K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 3, 2020 | Tomsicek Michael John | Chief Financial Officer | Sale+OE | 12,000 | $86.74 | $1,040,918.53 | -65.7% | |
| Jul 7, 2020 | Novak Rodger75 | President | Sale+OE | 25,000 | $90.00 | $2,250,000.00 | -3.7% | |
| Jul 6, 2020 | Bolzon Bradley J Phd75 | Director | Sell | 20,000 | $82.39 | $1,647,730.03 | -1.8% | |
| Jul 1, 2020 | Novak Rodger75 | President | Sell | 50,000 | $80.00 | $4,000,000.00 | -7.2% | |
| Jun 25, 2020 | Klein Lawrence Otto | Cbo &COO | Sale+OE | 70,000 | $75.88 | $5,311,564.12 | -22.8% | |
| Jun 23, 2020 | Novak Rodger75 | President | Sell | 50,000 | $75.00 | $3,750,000.00 | -6.7% | |
| Jun 23, 2020 | Ho Tony W | Executive VP, Head Of R&D | Sell | 7,158 | $75.04 | $537,122.86 | -8.8% | |
| Jun 23, 2020 | Bolzon Bradley J Phd75 | Director | Sell | 20,000 | $73.93 | $1,478,522.00 | -1.7% | |
| Jun 1, 2020 | Kulkarni Samarth68 | Chief Executive Officer | Sale+OE | 17,275 | $64.68 | $1,117,265.50 | -3.1% | |
| May 26, 2020 | Novak Rodger75 | President | Sell | 50,000 | $70.20 | $3,510,020.16 | -3.2% |